查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2014685

胃腸道支架市場：2026-2032年全球市場預測（按產品類型、材料、置入方法、應用、最終用戶和分銷管道分類）

Gastrointestinal Stents Market by Product Type, Material, Placement Method, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，胃腸道支架市場價值將達到 4.899 億美元，到 2026 年將成長至 5.2143 億美元，到 2032 年將達到 7.4426 億美元，複合年成長率為 6.15%。

主要市場統計數據
基準年 2025 4.899億美元
預計年份：2026年 5.2143億美元
預測年份 2032 7.4426億美元
複合年成長率 (%) 6.15%

簡要概述影響胃腸道支架短期策略決策的臨床因素、技術進步和商業性因素。

本執行摘要概述了胃腸道支架的最新發展趨勢，重點闡述了影響採購和研發決策的臨床需求、技術促進因素和商業性考量。內視鏡和透視技術的進步，以及支架材料和設計的不斷改進，已經改變了臨床醫生的選擇偏好和手術流程。同時，不斷變化的支付方期望和醫院供應鏈策略也在影響產品的評估和應用。

器械工程、混合手術方案和供應鏈重組的突破如何重塑胃腸道支架的臨床應用和商業策略。

胃腸道支架領域正經歷一場變革，這得益於器械工程技術的進步、手術流程的創新以及更一體化的病患診療路徑。諸如個人化徑向力分佈、防移位功能和親水塗層等設計改進，改變了臨床醫生對支架耐用性和易置性的預期。同時，結合內視鏡和透視技術的混合手術路徑的出現，拓展了支架的應用臨床場景，進而影響採購規範和訓練重點。

2025 年美國關稅調整對胃腸道支架的採購、本地化生產和分銷方式的實際影響。

關稅和貿易政策的變化將對醫療設備資本財和耗材的流通產生重大影響，預計2025年美國的關稅環境將為胃腸支架行業的相關人員帶來一系列營運挑戰和策略選擇。關稅調整會影響接收成本，進而影響醫院、門診中心和集團採購組織的採購決策。採購團隊可能會透過供應商多元化、轉向區域製造合作夥伴或重新談判合約以加入關稅轉嫁條款來應對。

將產品類型、材料、植入方法、最終用戶、應用和分銷管道與臨床引進和採購因素聯繫起來的詳細細分分析。

清晰了解細分市場對於使產品開發和商業策略與臨床及組織需求保持一致至關重要。根據產品類型，市場可細分為塑膠支架和自膨式金屬支架。自膨式金屬支架可進一步細分為塗層自膨式金屬支架和非塗層自膨式金屬支架。這種區分至關重要，因為塑膠支架和金屬支架之間，以及塗層支架和非塗層支架之間，手術方式的選擇、預期植入時間和併發症發生率均有顯著差異。按材料分類，市場可分為金屬和塑膠。這會影響製造過程、滅菌方法以及臨床醫生根據所治療的解剖部位和病理情況而做出的選擇。依植入方法分類，市場可分為內視鏡/透視輔助植入、內視鏡植入和透視輔助植入。每種植入方法都有其獨特的訓練要求、對醫療設備的依賴性，以及對術前術後工作流程的影響，這些都會影響其採用率。

透過對美洲、歐洲、中東和非洲以及亞太地區的比較區域分析，揭示了需求和投資優先事項的決定因素。

區域趨勢影響胃腸支架相關人員如何確定投資優先順序、建立分銷網路以及與臨床醫生互動。在美洲，整合的醫院系統、集中採購架構以及對實證醫學應用的重視影響著市場需求模式。這有利於那些能夠證明其臨床療效可靠並提供整合服務模式的供應商。相較之下，歐洲、中東和非洲地區的管理體制架構和採購方式各不相同，各國的報銷政策和區域性生產獎勵對於市場新進業者而言既可能是障礙，也可能是機會。在這些地區，個人臨床檢驗和靈活的商業條款往往是決定性因素。

製造商如何將平台模組化、臨床證據的創建和策略夥伴關係關係結合起來，以確保在臨床環境中得到應用並獲得採購交易？

胃腸道支架領域的競爭格局由產品差異化、臨床證據策略、策略夥伴關係共同構成​​。領先的製造商正日益重視模組化平台，使其能夠適應不同的解剖部位和適應症，從而提高規模經濟效益並簡化醫護人員的培訓。與醫療設備配件製造商、診斷公司和影像技術供應商的合作也十分普遍，從而能夠提供兼顧手術效率和臨床療效的捆綁式解決方案。此外，一些公司正在加強上市後監測和真實世界數據（RWE）項目，以支持擴大適應症範圍並與支付者進行談判。

可操作的、高優先順序的策略措施，旨在幫助製造商、供應商和臨床相關人員提高韌性、採用率和可衡量的價值交付。

產業相關人員應採取一系列切實可行的措施來增強韌性、差異化優勢和臨床影響力。首先，將產品開發與手術流程（特別是混合內視鏡和透視方法）結合，可以最大限度地減少培訓負擔和資本投入，從而降低推廣門檻。其次，投資於真實世界數據 (REW) 和上市後調查計畫，有助於與保險公司進行諮詢並拓展臨床適應症，從而促進產品納入醫療保險範圍。第三，探索供應鏈方案，包括本地組裝和零件採購，可以降低關稅和物流風險，同時縮短前置作業時間。

高度透明、多方面的調查方法，結合臨床訪談、文獻分析和供應鏈檢驗，為可靠的結論提供了支持。

本報告的結論是基於嚴謹的多源調查方法，旨在確保提供可操作的洞見和透明的可追溯性。主要研究包括對臨床負責人、採購專家和醫療設備公司高階主管進行結構化訪談，以了解他們對手術選擇標準、採購行為和服務期望的實際觀點。次要研究則利用同行評審的臨床文獻、監管文件和公開的企業資訊披露，來闡釋技術趨勢和證據要求。

一份綜合總結，重點闡述相關人員為應對胃腸道支架的臨床、商業性和監管變化而採取的策略重點。

總而言之，胃腸道支架市場面臨著多種因素交織的複雜壓力，包括臨床對微創和耐用解決方案的需求、供應商圍繞平台適應性和循證醫學證據的競爭，以及關稅變化和區域監管差異等外部因素。能夠將嚴格的臨床檢驗、靈活的分銷模式和區域客製化的供應鏈策略相結合的相關人員，將更有利於確保產品的永續應用。此外，在臨床療效和醫療總成本之間取得平衡至關重要的情況下，對臨床醫生培訓、上市後證據和整合服務交付的投資，將在採購決策中發揮關鍵作用。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：胃腸道支架市場：依產品類型分類

  • 塑膠支架
  • 自膨式金屬支架
    • 覆膜自膨式金屬支架
    • 無塗層自膨式金屬支架

第9章：胃腸道支架市場：依材料分類

  • 金屬
  • 塑膠

第10章：以置入方式分類的胃腸道支架市場

  • 採用內視鏡和透視相結合的方法進行定位
  • 內視鏡置入
  • 透視定位

第11章：胃腸道支架市場：依應用領域分類

  • 膽道阻塞
  • 結腸狹窄
  • 十二指腸阻塞
  • 食道狹窄
  • 胃出口阻塞

第12章：胃腸道支架市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院

第13章：胃腸支架市場：依通路分類

  • 直銷
  • 透過分銷商銷售

第14章：胃腸道支架市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章：胃腸道支架市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章：胃腸道支架市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國胃腸道支架市場

第18章：中國胃腸支架市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Arterial Remodeling Technologies SA
  • Arterius Ltd
  • B. Braun Melsungen AG
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Elixir Medical Corporation
  • JW Medical Systems LTD
  • Kaneka Corporation
  • KLS Martin Group
  • Kyoto Medical Planning Co. Ltd.
  • Medtronic Plc
  • Meril Life Sciences Pvt. Ltd.
  • Microport Scientific Corporation
  • OrbusNeich Medical
  • Q3 Medical Devices Limited.
  • Reva Medical
  • SafeGuard Surgical, Inc.
  • Smith & Nephew Plc
  • Stryker Corporation
  • Syntellix AG
  • Terumo Corporation
Product Code: MRR-437E9896A501

The Gastrointestinal Stents Market was valued at USD 489.90 million in 2025 and is projected to grow to USD 521.43 million in 2026, with a CAGR of 6.15%, reaching USD 744.26 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 489.90 million
Estimated Year [2026] USD 521.43 million
Forecast Year [2032] USD 744.26 million
CAGR (%) 6.15%

A concise orientation to gastrointestinal stent clinical drivers, technological progress, and commercial forces shaping near-term strategic decisions

This executive summary introduces the contemporary landscape of gastrointestinal stents, framing clinical imperatives, technological drivers, and commercial considerations that underpin procurement and development decisions. Advances in endoscopic and fluoroscopic techniques, coupled with iterative improvements in stent materials and designs, have reshaped clinician preferences and procedural workflows. At the same time, shifting payer expectations and hospital supply chain strategies are influencing how products are evaluated and adopted.

Clinically, the emphasis on minimally invasive solutions for obstructive pathologies and strictures has heightened reliance on stenting as both a bridge to definitive therapy and a palliative measure. From a commercial perspective, manufacturers and suppliers are navigating a convergence of innovation pressure and cost containment, which requires more nuanced product differentiation and evidence generation. This introduction summarizes the principal forces that will be explored in depth throughout the report, including procedural placement methods, material selection, end-user dynamics, and distribution channels, all of which coalesce to determine how stakeholders prioritize investments and partnerships going forward.

How device engineering breakthroughs, hybrid procedural protocols, and supply chain realignments are reshaping clinical use and commercial strategies in gastrointestinal stents

The landscape for gastrointestinal stents is undergoing transformative shifts driven by advances in device engineering, procedural innovation, and a more integrated approach to patient pathways. Design improvements such as tailored radial force profiles, anti-migration features, and hydrophilic coatings have changed clinician expectations for durability and deliverability. Simultaneously, the emergence of hybrid procedural pathways that combine endoscopic and fluoroscopic techniques has expanded the range of clinical scenarios where stents are viable, thereby influencing procurement specifications and training priorities.

In addition, supply chain realignments-prompted by regional manufacturing diversification and strategic partnerships between device makers and hospital systems-are altering time-to-procure dynamics and inventory management. Regulatory scrutiny around post-market surveillance and clinical evidence has intensified, leading manufacturers to invest in robust clinical data capture and real-world evidence strategies. Lastly, digital health adjuncts such as procedure planning software and remote monitoring capabilities are beginning to intersect with stent therapies, enabling new services and bundled care models that could reshape reimbursement discussions and provider contracting.

Practical implications of United States tariff adjustments in 2025 on procurement, manufacturing localization, and distribution approaches for gastrointestinal stents

Policy shifts in tariffs and trade policy can exert outsized influence on capital and consumable medical device flows, and the United States tariff environment anticipated for 2025 presents a set of operational challenges and strategic choices for stakeholders in gastrointestinal stents. Tariff adjustments affect landed costs, which in turn influence purchasing decisions by hospitals, ambulatory centers, and group purchasing organizations. Procurement teams may respond by diversifying supplier bases, shifting toward regional manufacturing partners, or renegotiating contracts to include tariff pass-through clauses.

Moreover, tariff-related cost pressure often accelerates evaluation of distribution models and inventory strategies. For some suppliers, increased import duties create incentives to localize key components or to establish assembly operations closer to major end markets. At the same time, providers may optimize formulary lists and standardize on stent platforms that balance clinical performance with total cost of ownership. Finally, policymakers' communication and timelines for tariff implementation materially affect contract renewals and capital planning, so stakeholders should build scenario-based procurement and manufacturing contingencies that allow rapid adaptation to regulatory changes.

Deep segmentation analysis linking product type, material, placement method, end-user, application and distribution channel to clinical adoption and procurement drivers

Segment-level clarity is essential for aligning product development and commercial strategies with clinical and institutional needs. Based on Product Type, the market is examined across Plastic Stent and Self-Expandable Metallic Stent, with the Self-Expandable Metallic Stent further analyzed across Covered Self-Expandable Metallic Stent and Uncovered Self-Expandable Metallic Stent; this differentiation matters because procedural selection, expected dwell time, and complication profiles vary markedly between plastic devices and metallic constructs, and between covered and uncovered variants. Based on Material, the market is studied across Metal and Plastic, which has implications for manufacturing processes, sterilization pathways, and clinician preference depending on targeted anatomy and pathology. Based on Placement Method, the market is studied across Combined Endoscopic Fluoroscopic Placement, Endoscopic Placement, and Fluoroscopic Placement, and each placement method carries distinct training requirements, capital equipment dependencies, and peri-procedural workflow impacts that influence adoption rates.

Based on End User, the market is studied across Ambulatory Surgical Center, Clinic, and Hospital, and differences in procedural volumes, reimbursement models, and facility resources shape purchasing priorities and stocking practices. Based on Application, the market is studied across Biliary Obstruction, Colorectal Stricture, Duodenal Obstruction, Esophageal Stricture, and Gastric Outlet Obstruction, and clinical outcomes, patient comorbidities, and interdisciplinary care pathways vary by indication, informing evidence needs and labeling strategies. Finally, based on Distribution Channel, the market is studied across Direct Sales and Distributor Sales, each of which presents different margin structures, service expectations, and opportunities for value-added clinical support. Taken together, these segmentation dimensions illuminate where clinical need, purchasing behavior, and differentiation opportunities intersect, enabling stakeholders to prioritize development and commercial investments with greater precision.

Comparative regional intelligence across Americas, Europe Middle East & Africa, and Asia-Pacific highlighting demand determinants and investment priorities

Regional dynamics shape how gastrointestinal stent stakeholders prioritize investments, structure distribution, and engage with clinicians. In the Americas, demand patterns are influenced by consolidated hospital systems, centralized procurement frameworks, and an emphasis on evidence-based adoption; these conditions favor suppliers who can demonstrate robust clinical outcomes and offer integrated service models. In contrast, Europe, Middle East & Africa exhibits a spectrum of regulatory regimes and procurement approaches, where national reimbursement policies and local manufacturing incentives can create both barriers and opportunities for market entrants. In this region, tailored clinical validation and flexible commercial terms often prove decisive.

Asia-Pacific presents a heterogeneous landscape driven by rapid capacity expansion in tertiary care, varying regulatory pathways, and a growing focus on minimally invasive therapies. Manufacturers that invest in regional clinical partnerships, local training programs, and supply chain footholds tend to gain traction. Across all regions, differences in hospital infrastructure, availability of specialized proceduralists, and payer arrangements influence where innovation is first adopted and how product portfolios are prioritized. Therefore, regional go-to-market strategies must reconcile global product standards with local clinical and commercial realities to achieve sustainable adoption.

How manufacturers are combining platform modularity, clinical evidence generation, and strategic partnerships to secure clinical adoption and procurement wins

Competitive dynamics in gastrointestinal stents combine product differentiation, clinical evidence strategies, and strategic partnerships. Leading manufacturers increasingly prioritize modular platforms that can be adapted across anatomical sites and indications, thereby improving economies of scale and simplifying provider training. Partnerships with device accessory makers, diagnostic companies, and imaging technology vendors are also prevalent, enabling bundled solutions that address procedural efficiency and clinical outcomes. Moreover, some firms are strengthening post-market surveillance and real-world evidence programs to support labeling extensions and payer negotiations.

Innovation is frequently accompanied by targeted go-to-market plays such as center-of-excellence programs, hands-on clinician training, and outcomes-based contracts that align incentives across stakeholders. Smaller, specialized firms often focus on niche applications or novel coatings and delivery mechanisms to differentiate from incumbents, while larger manufacturers leverage distribution networks and service capabilities to secure hospital formularies. In aggregate, competitive positioning is less about single-product superiority and more about demonstrating total clinical and operational value in a way that resonates with procurement committees, clinicians, and payers.

Practical, prioritized strategic moves for manufacturers, suppliers, and clinical stakeholders to enhance resilience, adoption, and measurable value delivery

Industry participants should pursue a set of actionable measures to strengthen resilience, differentiation, and clinical impact. First, aligning product development with procedural workflows-particularly hybrid endoscopic-fluoroscopic approaches-will reduce barriers to adoption by minimizing training friction and capital expenditure. Second, investing in real-world evidence and post-market surveillance programs will support payer discussions and broaden clinical labeling, thereby improving formulary acceptance. Third, evaluating supply chain options that include regional assembly or component sourcing can mitigate tariff and logistics risks while shortening lead times.

Additionally, commercial teams should tailor channel strategies to end-user profiles, prioritizing direct-sales engagement for high-volume hospital systems and distributor partnerships where broad geographic reach and local regulatory know-how are required. Clinical education programs that combine simulation, proctoring, and outcomes tracking can accelerate clinician confidence and procedural volume. Finally, consider pursuing bundled service offerings that integrate devices with planning tools, training, and post-procedural follow-up to articulate a compelling total-cost-and-outcome value proposition to providers and payers alike.

A transparent multi-source research methodology integrating clinical interviews, literature synthesis, and supply chain verification to underpin trustworthy conclusions

The report's conclusions are underpinned by a rigorous, multi-source research methodology designed to ensure actionable insights and transparent traceability. Primary research included structured interviews with clinical leaders, procurement specialists, and device company executives to capture practical perspectives on procedural preferences, purchasing behavior, and service expectations. Secondary research drew on peer-reviewed clinical literature, regulatory documentation, and publicly available company disclosures to contextualize technology trends and evidence requirements.

Analytical steps included cross-validation of interview findings against published clinical outcomes and procedural guidelines, as well as supply chain verification through distributor and logistics partner consultations. The synthesis emphasizes reproducibility by documenting assumptions and evidence sources, and it applies qualitative scenario analysis to examine policy and supply-chain contingencies. Wherever possible, assertions were corroborated by multiple independent sources to reduce single-source bias and to provide a defensible basis for strategic recommendations.

Consolidated takeaways emphasizing strategic priorities for stakeholders to navigate clinical, commercial, and regulatory shifts in gastrointestinal stents

In conclusion, the gastrointestinal stent landscape is characterized by converging pressures: clinical demand for minimally invasive, durable solutions; vendor competition centered on platform adaptability and evidence generation; and external forces such as tariff changes and regional regulatory variability. Stakeholders that combine disciplined clinical validation, flexible distribution models, and localized supply chain strategies will be best positioned to capture sustained adoption. Moreover, investments in clinician training, post-market evidence, and integrated service offerings will prove decisive in environments where procurement decisions balance clinical outcomes against total cost of care.

Looking ahead, successful organizations will be those that translate technical innovation into demonstrated procedural advantages and operational efficiencies while maintaining agility in sourcing and commercialization. By prioritizing these strategic levers, manufacturers, providers, and distributors can navigate shifting policy landscapes and evolving clinical pathways to deliver better patient outcomes and stronger commercial performance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Gastrointestinal Stents Market, by Product Type

  • 8.1. Plastic Stent
  • 8.2. Self-Expandable Metallic Stent
    • 8.2.1. Covered Self-Expandable Metallic Stent
    • 8.2.2. Uncovered Self-Expandable Metallic Stent

9. Gastrointestinal Stents Market, by Material

  • 9.1. Metal
  • 9.2. Plastic

10. Gastrointestinal Stents Market, by Placement Method

  • 10.1. Combined Endoscopic Fluoroscopic Placement
  • 10.2. Endoscopic Placement
  • 10.3. Fluoroscopic Placement

11. Gastrointestinal Stents Market, by Application

  • 11.1. Biliary Obstruction
  • 11.2. Colorectal Stricture
  • 11.3. Duodenal Obstruction
  • 11.4. Esophageal Stricture
  • 11.5. Gastric Outlet Obstruction

12. Gastrointestinal Stents Market, by End User

  • 12.1. Ambulatory Surgical Center
  • 12.2. Clinic
  • 12.3. Hospital

13. Gastrointestinal Stents Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. Distributor Sales

14. Gastrointestinal Stents Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Gastrointestinal Stents Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Gastrointestinal Stents Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Gastrointestinal Stents Market

18. China Gastrointestinal Stents Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. Arterial Remodeling Technologies SA
  • 19.7. Arterius Ltd
  • 19.8. B. Braun Melsungen AG
  • 19.9. BIOTRONIK SE & Co. KG
  • 19.10. Boston Scientific Corporation
  • 19.11. Elixir Medical Corporation
  • 19.12. JW Medical Systems LTD
  • 19.13. Kaneka Corporation
  • 19.14. KLS Martin Group
  • 19.15. Kyoto Medical Planning Co. Ltd.
  • 19.16. Medtronic Plc
  • 19.17. Meril Life Sciences Pvt. Ltd.
  • 19.18. Microport Scientific Corporation
  • 19.19. OrbusNeich Medical
  • 19.20. Q3 Medical Devices Limited.
  • 19.21. Reva Medical
  • 19.22. SafeGuard Surgical, Inc.
  • 19.23. Smith & Nephew Plc
  • 19.24. Stryker Corporation
  • 19.25. Syntellix AG
  • 19.26. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GASTROINTESTINAL STENTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL GASTROINTESTINAL STENTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY PLACEMENT METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES GASTROINTESTINAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA GASTROINTESTINAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY PLASTIC STENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY PLASTIC STENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY PLASTIC STENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY COVERED SELF-EXPANDABLE METALLIC STENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY COVERED SELF-EXPANDABLE METALLIC STENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY COVERED SELF-EXPANDABLE METALLIC STENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY UNCOVERED SELF-EXPANDABLE METALLIC STENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY UNCOVERED SELF-EXPANDABLE METALLIC STENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY UNCOVERED SELF-EXPANDABLE METALLIC STENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY METAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY METAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY METAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY PLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY COMBINED ENDOSCOPIC FLUOROSCOPIC PLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY COMBINED ENDOSCOPIC FLUOROSCOPIC PLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY COMBINED ENDOSCOPIC FLUOROSCOPIC PLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY ENDOSCOPIC PLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY ENDOSCOPIC PLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY ENDOSCOPIC PLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY FLUOROSCOPIC PLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY FLUOROSCOPIC PLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY FLUOROSCOPIC PLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY BILIARY OBSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY BILIARY OBSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY BILIARY OBSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY COLORECTAL STRICTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY COLORECTAL STRICTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY COLORECTAL STRICTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY DUODENAL OBSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY DUODENAL OBSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY DUODENAL OBSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY ESOPHAGEAL STRICTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY ESOPHAGEAL STRICTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY ESOPHAGEAL STRICTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY GASTRIC OUTLET OBSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY GASTRIC OUTLET OBSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY GASTRIC OUTLET OBSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS GASTROINTESTINAL STENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS GASTROINTESTINAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS GASTROINTESTINAL STENTS MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS GASTROINTESTINAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA GASTROINTESTINAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA GASTROINTESTINAL STENTS MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA GASTROINTESTINAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA GASTROINTESTINAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA GASTROINTESTINAL STENTS MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA GASTROINTESTINAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE GASTROINTESTINAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE GASTROINTESTINAL STENTS MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE GASTROINTESTINAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST GASTROINTESTINAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST GASTROINTESTINAL STENTS MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST GASTROINTESTINAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC GASTROINTESTINAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC GASTROINTESTINAL STENTS MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC GASTROINTESTINAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN GASTROINTESTINAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN GASTROINTESTINAL STENTS MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN GASTROINTESTINAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. GCC GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GCC GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. GCC GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, 2018-2032 (USD MILLION)
  • TABLE 143. GCC GASTROINTESTINAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 144. GCC GASTROINTESTINAL STENTS MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 145. GCC GASTROINTESTINAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. GCC GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. GCC GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION GASTROINTESTINAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION GASTROINTESTINAL STENTS MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION GASTROINTESTINAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS GASTROINTESTINAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS GASTROINTESTINAL STENTS MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS GASTROINTESTINAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. G7 GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. G7 GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. G7 GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, 2018-2032 (USD MILLION)
  • TABLE 167. G7 GASTROINTESTINAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 168. G7 GASTROINTESTINAL STENTS MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 169. G7 GASTROINTESTINAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. G7 GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. G7 GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 172. NATO GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. NATO GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. NATO GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, 2018-2032 (USD MILLION)
  • TABLE 175. NATO GASTROINTESTINAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 176. NATO GASTROINTESTINAL STENTS MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 177. NATO GASTROINTESTINAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. NATO GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. NATO GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL GASTROINTESTINAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES GASTROINTESTINAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED STATES GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES GASTROINTESTINAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES GASTROINTESTINAL STENTS MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES GASTROINTESTINAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA GASTROINTESTINAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA GASTROINTESTINAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. CHINA GASTROINTESTINAL STENTS MARKET SIZE, BY SELF-EXPANDABLE METALLIC STENT, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA GASTROINTESTINAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA GASTROINTESTINAL STENTS MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA GASTROINTESTINAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA GASTROINTESTINAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA GASTROINTESTINAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)